Skip to main content
Erschienen in: Reactions Weekly 1/2014

01.12.2014 | Case report

Tegafur/uracil

Transient leucopenia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Twu C-W, et al. Metronomic adjuvant chemotherapy improves treatment outcome in nasopharyngeal carcinoma patients with postradiation persistently detectable plasma epstein-barr virus deoxyribonucleic acid. International Journal of Radiation Oncology, Biology, Physics 89: 21-29, No. 1, May 2014. Available from: URL: http://doi.org/10.1016/j.ijrobp.2014.01.052 - TaiwanPubMedCrossRef Twu C-W, et al. Metronomic adjuvant chemotherapy improves treatment outcome in nasopharyngeal carcinoma patients with postradiation persistently detectable plasma epstein-barr virus deoxyribonucleic acid. International Journal of Radiation Oncology, Biology, Physics 89: 21-29, No. 1, May 2014. Available from: URL: http://​doi.​org/​10.​1016/​j.​ijrobp.​2014.​01.​052 - TaiwanPubMedCrossRef
Metadaten
Titel
Tegafur/uracil
Transient leucopenia: case report
Publikationsdatum
01.12.2014
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2014
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-014-6002-0

Weitere Artikel der Ausgabe 1/2014

Reactions Weekly 1/2014 Zur Ausgabe

Case report

Methotrexate

Case report

Nimotuzumab

Case report

Interferon-α

Case report

Sorafenib